| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.003 | 1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |